The Centers for Disease Control and Prevention on Thursday released new recommendations to treat latent tuberculosis infection.
Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.
Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.